American Heart Journal
Volume 147, Issue 6 , Pages 977-984 , June 2004

Part I: identifying holes in the safety net

  • J.Conor O'Shea, MD

      Affiliations

    • Duke Center for Education and Research on Therapeutics (CERTs) Research Center, Duke Clinical Research Institute, Durham, NCUSA
    • ,
  • Judith M Kramer, MD, MS

      Affiliations

    • Duke Center for Education and Research on Therapeutics (CERTs) Research Center, Duke Clinical Research Institute, Durham, NCUSA
    • ,
  • Robert M Califf, MD, FACC

      Affiliations

    • Duke Center for Education and Research on Therapeutics (CERTs) Research Center, Duke Clinical Research Institute, Durham, NCUSA
    • ,
  • Eric D Peterson, MD, MPH

      Affiliations

    • Duke Center for Education and Research on Therapeutics (CERTs) Research Center, Duke Clinical Research Institute, Durham, NCUSA
    • Corresponding Author InformationReprint requests: Eric D. Peterson, MD, MPH, Duke Clinical Research Institute, P.O. Box 3236, Durham, NC 27705, USA.

References 

  1. Kessler L, Richter K. Technology assessment of medical devices at the Center for Devices and Radiological Health. Am J Manag Care 1998;4:SP129–35
  2. Medical Device Amendments of 1976. Pub L No. 94-295, 90 Stat 539, 1976
  3. Federal Food, Drug and Cosmetic Act of 1938. Pub L No. 75-717, 52 Stat 1040, 1938, as amended 21 USC §301 et seq, 1988
  4. Safe Medical Devices Act of 90. Pub L No. 101-629, 104 Stat 4511, 1990
  5. FDA Modernization Act. Pub L No. 105-115, 111 Stat 2296, 1997
  6. Medical Device User Fee and Modernization Act of 2002 (October 16, 2002). Publ L 107-250. HR.5651.EH. Available at: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107_cong_bills&docid=f:h5651eh.txt. Accessed December 9, 2002
  7. US Food and Drug Administration. 21 CFR 860.3 Medical Device Classification Procedures: Definitions. Available at: http://frwebgate.access.gpo.gov/cgi-bin/get-cfr.cgi?TITLE=21&PART=860&SECTION=3&YEAR=2002&TYPE=TEXT. Accessed December 9, 2002
  8. Federal Food, Drug and Cosmetic Act of 38. Pub L No. 75-717, 52 Stat 1040, 1938, as amended 21 USC §301 et seq, 1988. Section 513. Classes of Devices
  9. Gross TP, Kessler LG. Medical device vigilance at FDA. Stud Health Technol Inform. 1996;28:17–24
  10. Kessler DA. Introducing MEDWatch (a new approach to reporting medication and device adverse effects and product problems). JAMA. 1993;269:2765–2768
  11. Food and Drug Administration. Designing a Medical Device Surveillance Network. FDA Report to Congress. Rockville (Md): US Food and Drug Administration; September 1999
  12. FDA Enforcement Report Index. Available at: http://www.fda.gov/opacom/enforce.html. Accessed December 9, 2003
  13. Maisel WH, Sweeney MO, Stevenson WG, et al.  Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators. JAMA. 2001;286:793–799
  14. McEnany MT, Wheeler EO, Austen WG. Survival following fracture of strut from mitral prosthesis with disc translocation. J Thorac Cardiovasc Surg. 1979;78:136–139
  15. O'Neill WW, Chandler JG, Gordon RE, et al.  Radiographic detection of strut separations in Bjork-Shiley convexo-concave mitral valves. N Engl J Med. 1995;333:414–420
  16. Hutter JC, Long MC, Luu HM, et al.  Prediction of the shelf life of cellulose acetate hemodialyzers by Monte Carlo simulation. ASAIO J. 2001;47:522–527
  17. Lucas AD, Kalson JA, Hutter JC, et al.  Identifying toxic degradation products in cellulose acetate dialyzers. J Biomed Mater Res. 2000;53:449–456
  18. Schaff H, Carrel T, Steckelberg JM, et al.  Artificial Valve Endocarditis Reduction Trial (AVERT) (protocol of a multicenter randomized trial). J Heart Valve Dis. 1999;8:131–139
  19. Schaff HV, Carrel TP, Jamieson WR, et al.  Paravalvular leak and other events in silzone-coated mechanical heart valves (a report from AVERT). Ann Thorac Surg. 2002;73:785–792
  20. Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med. 1999;341:1021–1028
  21. Bridges CR. Myocardial laser revascularization (the controversy and the data). Ann Thorac Surg. 2000;69:655–662
  22. Allen KB, Dowling RD, Fudge TL, et al.  Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med. 1999;341:1029–1036
  23. Peterson ED, Kaul P, Kaczmarek RG, et al.  From controlled trials to clinical practice (monitoring transmyocardial revascularization use and outcomes). J Am Coll Cardiol. 2003;42:1611–1616
  24. Sapirstein W, Zuckerman B, Dillard J. FDA approval of coronary-artery brachytherapy. N Engl J Med. 2001;344:297–299
  25. Peterson ED, Lansky AJ, Anstrom KJ, et al.  Evolving trends in interventional device use and outcomes (Results from the National Cardiovascular Network database). Am Heart J. 2000;139:8–207
  26. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data: the Novoste Beta-Cath System. November 3, 2000. Available at: http://www.fda.gov/cdrh/pdf/p000018.html. Accessed November 15, 2002
  27. Food and Drug Administration, Center for Devices and Radiological Health. Summary of Safety and Effectiveness Data: the Cordis Checkmate System. November 3, 2000. Available at: http://www.fda.gov/cdrh/pdf/p990036.html. Accessed November 15, 2002
  28. Serruys PW, Degertekin M, Tanabe K, et al.  Intravascular ultrasound findings in the multicenter, randomized double-blind RAVEL (Randomized study with the sirolimus-eluting Velocity Balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation. 2002;106:798–803
  29. Moses JW, Leon MB, Popma JJ, et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  30. Altman LK. The Doctor's World: Doctors Look for Source of Stent Complications. New York Times. November 18, 2003;Health & Fitness:F5

☆ Supported in part by an Agency for Healthcare Research and Quality (AHRQ) Centers for Education and Research on Therapeutics cooperative agreement (Grant # U18HS10548).Published online May 20, 2004.

PII: S0002-8703(04)00109-7

doi: 10.1016/j.ahj.2004.03.001

American Heart Journal
Volume 147, Issue 6 , Pages 977-984 , June 2004

Article Tools